Advertisement

Myocardial Infarction

Rheumatoid Arthritis Linked to Comorbidities Before, After Diagnosis

Nov 20, 2019

There are associations between rheumatoid arthritis (RA) and multiple comorbidities before and after diagnosis, with inflammatory bowel disease, type 1 diabetes, and venous thromboembolism (VTE) occur...

Vigorous Activity Weekly May Improve Outcomes in Stable CAD

Nov 20, 2019

WEDNESDAY, Nov. 20, 2019 (HealthDay News) -- Performing vigorous physical activity once or twice a week compared with sedentary behavior or light physical activity may improve long-term cardiac health...

Rheumatoid Arthritis Linked to Comorbidities Before, After Diagnosis

Nov 20, 2019

WEDNESDAY, Nov. 20, 2019 (HealthDay News) -- There are associations between rheumatoid arthritis (RA) and multiple comorbidities before and after diagnosis, with inflammatory bowel disease, type 1 dia...

AHA: Lower-Target LDL Level Beneficial After Stroke, TIA

Nov 19, 2019

TUESDAY, Nov. 19, 2019 (HealthDay News) -- For patients with ischemic stroke or transient ischemic attack (TIA) with evidence of atherosclerosis, those with a target low-density lipoprotein (LDL) chol...

AHA: Lower-Target LDL Level Beneficial After Stroke, TIA

Nov 19, 2019

TUESDAY, Nov. 19, 2019 (HealthDay News) -- For patients with ischemic stroke or transient ischemic attack (TIA) with evidence of atherosclerosis, those with a target low-density lipoprotein (LDL) chol...

AHA: Impact of Valsartan Recall Examined for Ontario, Canada

Nov 18, 2019

MONDAY, Nov. 18, 2019 (HealthDay News) -- The generic valsartan recall has had population-level impacts on patients in Ontario, Canada, according to a research letter published online Nov. 11 in Circu...

AHA: Risk for Ischemic CV Events Lower With Colchicine After MI

Nov 18, 2019

MONDAY, Nov. 18, 2019 (HealthDay News) -- Patients with recent myocardial infarction have a lower risk for ischemic cardiovascular events with colchicine versus placebo, according to a study published...

AHA: Impact of Valsartan Recall Examined for Ontario, Canada

Nov 18, 2019

MONDAY, Nov. 18, 2019 (HealthDay News) -- The generic valsartan recall has had population-level impacts on patients in Ontario, Canada, according to a research letter published online Nov. 11 in Circu...

AHA: Risk for Ischemic CV Events Lower With Colchicine After MI

Nov 18, 2019

MONDAY, Nov. 18, 2019 (HealthDay News) -- Patients with recent myocardial infarction have a lower risk for ischemic cardiovascular events with colchicine versus placebo, according to a study published...

The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure

Nov 14, 2019

Heart failure (HF) is the most frequent cardiovascular diagnosis and exacts significant health and financial costs around the globe. It is estimated that at least 26 million people worldwide are livin...

AHA: Cardiovascular Risk Factors Tied to Increased Cancer Risk

Nov 12, 2019

TUESDAY, Nov. 12, 2019 (HealthDay News) -- Cardiovascular (CV) risk factors and cardiovascular disease (CVD) are associated with an increased risk for developing cancer, according to a study presented...

AHA: Cardiovascular Risk Factors Tied to Increased Cancer Risk

Nov 12, 2019

TUESDAY, Nov. 12, 2019 (HealthDay News) -- Cardiovascular (CV) risk factors and cardiovascular disease (CVD) are associated with an increased risk for developing cancer, according to a study presented...

Women Less Likely to Receive Treatment for Myocardial Infarction

Nov 06, 2019

WEDNESDAY, Nov. 6, 2019 (HealthDay News) -- Use of sex-specific diagnostic thresholds for myocardial infarction identifies more additional women than men with myocardial injury, but women are less lik...

Women Less Likely to Receive Treatment for Myocardial Infarction

Nov 06, 2019

WEDNESDAY, Nov. 6, 2019 (HealthDay News) -- Use of sex-specific diagnostic thresholds for myocardial infarction identifies more additional women than men with myocardial injury, but women are less lik...

October 2019 Briefing - Pharmacy

Nov 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for October 2019. This roundup includes the latest research news from journal articles, as well as the...

Equivalence Seen Between Drug Classes for HTN Monotherapy

Nov 01, 2019

FRIDAY, Nov. 1, 2019 (HealthDay News) -- Most estimates show no differences in effectiveness between classes of antihypertensive agents, according to a systematic, multinational, large-scale analysis ...

October 2019 Briefing - Cardiology

Nov 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2019. This roundup includes the latest research news from journal articles, as well as t...

October 2019 Briefing - Family Practice

Nov 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for October 2019. This roundup includes the latest research news from journal articles, as well...

October 2019 Briefing - Surgery

Nov 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Surgery for October 2019. This roundup includes the latest research news from journal articles, as well as the ...

October 2019 Briefing - Internal Medicine

Nov 01, 2019

Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for October 2019. This roundup includes the latest research news from journal articles, as we...